Abstract
The patient was a 24-year-old female who presented for her annual gynecologic exam. Her last pap smear was one year ago and was normal. She had been sexually active in the past. She requested a refill of the birth control pills that she takes. She reported regular menstrual cycles of approximately 28 days without complaints or problems and no prior sexually transmitted infections or pregnancies. The patient’s past medical history did not include hospitalizations. Her immunizations were up to date, including receiving the series of three human papillomavirus (HPV) vaccinations two years prior to her presentation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bosch FX, de Sanjose S (2003) Chapter 1: Human papillomavirus and cervical cancer–burden and assessment of causality. J Natl Cancer Inst Monogr 2003:3–13
Solomon D, Davey D, Kurman R et al (2002) The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287:2114–2119
McMurray HR, Nguyen D, Westbrook TF et al (2001) Biology of human papillomaviruses. Int J Exp Pathol 82:15–33
Solomon D, Schiffman M, Tarone R (2001) Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 93:293–299
Wright TC Jr, Massad LS, Dunton CJ et al (2007) 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197:346–355
Nanda K, McCrory DC, Myers ER et al (2000) Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 132:810–819
Fahey MT, Irwig L, Macaskill P (1995) Meta-analysis of pap test accuracy. Am J Epidemiol 141:680–689
Wright TC (2006) HPV DNA testing for cervical cancer screening. Int J Gynaecol Obstet 95:S239–S246
Khan MJ, Castle PE, Lorincz AT et al (2005) The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97:1072–1079
Castle PE, Solomon D, Wheeler CM et al (2008) Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol 46:2595–2604
Baylor NW, Wharton M (2009) Efficacy data and HPV Âvaccination studies. JAMA 302:2658–2659
Markowitz LE, Dunne EF, Saraiya M et al (2007) Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 56:1–24
Ault KA (2007) Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 369:1861–1868
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Arbefeville, S.S., Bossler, A.D. (2011). Human Papillomavirus. In: Schrijver, I. (eds) Diagnostic Molecular Pathology in Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19677-5_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-19677-5_33
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-19676-8
Online ISBN: 978-3-642-19677-5
eBook Packages: MedicineMedicine (R0)